National Storage Mechanism | Additional information
RNS Number : 4263W
Bank of Queensland Limited
22 December 2021
 

SUPPLEMENT DATED 21 DECEMBER 2021

 

 

 

Bank of Queensland Limited (ABN 32 009 656 740)

(incorporated with limited liability in the Commonwealth of Australia)

U.S.$4,000,000,000 Euro Medium Term Note Programme

 

This Supplement (the Supplement) to the Information Memorandum (the Information Memorandum) dated 20 April 2021 which comprises a base prospectus for the purposes of the UK Prospectus Regulation constitutes a supplement to the prospectus for the purposes of Article 23 of the UK Prospectus Regulation and is prepared in connection with the BOQ Euro Medium Term Note Programme (the Programme) established by the Bank of Queensland (the Issuer). Terms defined in the Information Memorandum have the same meaning when used in this Supplement. When used in this Supplement, UK Prospectus Regulation means Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (EUWA).

 

This Supplement is supplemental to, and should be read in conjunction with, the Information Memorandum and any other supplements to the Information Memorandum issued by the Issuer.  A copy of this Supplement and the information which is incorporated by reference in the Information Memorandum will be made available for inspection at the offices of the Issuer and at the offices of the Principal Paying Agent for so long as the Programme remains in existence.  This Supplement and the information which is incorporated by reference in the Information Memorandum will be published on the website of the Regulatory News Service operated by the London Stock Exchange at http://www.londonstockexchange.com/exchange/news/market-news/market-news-home.html and is available, without charge, on the internet site www.boq.com.au. Other than in relation to the documents which are deemed to be incorporated by reference in the Information Memorandum by virtue of this Supplement, the information on the websites to which this Supplement refers does not form part of this Supplement and has not been scrutinised or approved by the FCA.

 

The Issuer accepts responsibility for the information contained in this Supplement. To the best of the knowledge of the Issuer the information contained in this Supplement is in accordance with the facts and this Supplement makes no omission likely to affect the import of such information.

The purpose of this Supplement is to: (i) incorporate by reference the Issuer's annual financial statements as at and for the 12 month period ended 31 August 2021; (ii) confirm that since 31 August 2021, being the end date for the financial period for which audited annual consolidated and non-consolidated financial statements of the Issuer have been published, there has been no significant change in the financial performance or financial position of the Group and no material adverse change in the prospects of the Issuer; (iii) provide an update of the announced board changes for the Issuer being that on 5 August 2021, Deborah Kiers was appointed as a Non-Executive Independent Director, on 13 October 2021, Dr Jenny Fagg was appointed as a Non-Executive Independent Director and the retirement of John Lorimer and Kathleen Bailey-Lord as Non-Executive Independent Directors, effective as of 7 December 2021 and 5 August 2021, respectively; and (iv) confirm that as at the date of this Supplement there are no existing or potential conflicts of interests between any duties owed to the Issuer by its Directors and the private interests or external duties of those Directors.

To the extent that there is any inconsistency between (a) any statement in this Supplement or any statement incorporated by reference into the Information Memorandum by this Supplement and (b) any other statement in or incorporated by reference in the Information Memorandum, the statements in (a) above will prevail.

Save as disclosed in this Supplement, there has been no other significant new factor, material mistake or material inaccuracy relating to information included in the Information Memorandum since the publication of the Information Memorandum.

Updates to the Information Memorandum

Additional Financial Information

Bank of Queensland Annual Report 2021

On 13 October 2021, the Issuer published its Annual Report (the 2021 Annual Report) which includes the Issuer's audited annual consolidated and non-consolidated financial statements (including the directors' report, auditor's report thereon and notes thereto) in respect of the year ended 31 August 2021 (as set out from page 11 to page 75 and from page 108 to page 182 of the 2021 Annual Report). By virtue of this Supplement, those audited annual consolidated and non-consolidated financial statements (including the directors' report, auditor's report thereon and notes thereto) as set out on the pages specified above shall be deemed to be incorporated in, and form part of, the Information Memorandum. A copy of the 2021 Annual Report has been filed with the FCA and is available for viewing at https://www.boq.com.au/content/dam/boq/files/shareholder-centre/financial-results/2021/annual-report-2021.pdf

If any information set out on the pages of the 2021 Annual Report specified above itself incorporates any information or other documents therein, either expressly or implicitly, such information or other documents will not form part of the Information Memorandum, except where such information or other documents are specifically incorporated by reference in, or attached to, the Information Memorandum by virtue of this Supplement. The non-incorporated parts of the 2021 Annual Report do not form part of the Information Memorandum and is given for information only. The non-incorporated parts of the 2021 Annual Report are either not relevant or are covered elsewhere in the Information Memorandum to which this Supplement relates.

Significant or Material Change

There has been no significant change in the financial performance or financial position of the Group since 31 August 2021 and no material adverse change in the prospects of the Issuer since 31 August 2021.

Board Changes

Effective as of 5 August 2021, Deborah Kiers was appointed as a Non-Executive Independent Director of the Issuer.

Effective as of 13 October 2021 , Dr Jenny Fagg was appointed as a Non-Executive Director of the Issuer.

The following biographies are added to the end of the list of Director biographies in the section entitled "Bank of Queensland Limited - Directors" on page 193 of the Base Prospectus:

Name, qualifications and independence status

 

Experience, special responsibilities and other Directorships

Deborah Kiers

B.Sc (Hons), MPA, MAICD


Non-Executive Independent Director

 

Ms Kiers was appointed as a Non-Executive Director of the Bank in August 2021.

Ms Kiers previously acted as a Director of ME Bank since July 2020 and acted as Chair of the ME Bank Board's People and Culture sub-committee and as a member of the Risk and Compliance Committee.

Ms Kiers brings over 30 years of strategic, advisory and consulting experience to boards and executive management teams across a wide range of industries including Financial Services, Energy and Resources, Industrials, Property, Infrastructure and Regulated Utilities, both in Australia and internationally.

As Managing Director of JMW Consultants (Asia Pacific), Ms Kiers's support for companies included strategic advice, business model transformations, M&A integration, leadership transition and development for CEOs, executive teams and board directors, as well as building synergies between culture, performance and remuneration strategies.

Ms Kiers is currently a Non-Executive Director for IFM Investors and holds the position of Chair of the IFM Board Responsible Investment and Sustainability Committee and is a member of the Board Audit and Risk Committee. Ms Kiers is also a Non-Executive Director of the Tiverton Agriculture Impact Fund.

Ms Kiers is a member of the Audit, Risk, Nomination & Governance, People, Culture and Remuneration, and Transformation & Technology Committees.

Dr. Jenny Fagg

PhD B Econ


Non-Executive Independent Director

 

Dr Fagg was appointed a Director of BOQ on 13 October 2021.

Dr Fagg brings to the Board more than 25 years executive experience across leading financial services institutions in Australia and abroad. Most recently Dr Fagg served as Chief Risk Officer for AMP Limited driving a critical transformation agenda for risk culture and systems following the Hayne Royal Commission. She is recognised for her leadership capability and turnaround credentials fostered during her time at CIBC, Canada and many years at ANZ where she was CEO of ANZ Bank, New Zealand and also led the Consumer Finance division. Dr Fagg has a PhD in Management (Risk), from University of Sydney's Graduate School of Business and also holds a Bachelor of Economics (Honours in Psychology) from the University of Queensland.

Dr Fagg is a member of BOQ's Transformation & Technology, Risk, People, Culture & Remuneration, Audit, and Nomination & Governance Committees.

On 7 December 2021, John Lorimer retired as a Non-Executive Independent Director from the Board of the Issuer. Accordingly, the biography of John Lorimer as set out on page 192 of the Base Prospectus is deleted in its entirety.

On 5 August 2021, Kathleen Bailey-Lord retired as a Non-Executive Independent Director from the Board of the Issuer. Accordingly, the biography of Kathleen Bailey-Lord as set out on pages 192-193 of the Base Prospectus is deleted in its entirety.

As at the date of this Supplement there are no existing or potential conflicts of interests between any duties owed to the Issuer by its Directors and the private interests or external duties of those Directors.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PSPPPGQGPUPGUUP